Jiangsu Aidea Pharmaceutical Co Ltd (688488) — Cash Flow Reinvestment Rate
Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a Cash Flow Reinvestment Rate of 0.51x as of September 2025, reinvesting CN¥1.81 Million (capex CN¥1.81 Million ) from operating cash flow of CN¥3.56 Million. Explore 688488 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jiangsu Aidea Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2016–2020)
Historical reinvestment intensity for Jiangsu Aidea Pharmaceutical Co Ltd across 3 annual periods. Also explore 688488 current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Jiangsu Aidea Pharmaceutical Co Ltd (2016–2020)
Year-by-year capital reinvestment analysis for Jiangsu Aidea Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 688488 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 10.28x | CN¥577.43 Million | CN¥56.17 Million | CN¥42.43 Million | ▲ +1439.1% |
| 2019 | 0.67x | CN¥37.54 Million | CN¥56.20 Million | CN¥33.50 Million | ▼ -70.6% |
| 2016 | 2.27x | CN¥71.01 Million | CN¥31.29 Million | CN¥71.01 Million | — |